Tuesday, May 05, 2020 2:36:20 PM
Ultimately, for all the good intentions of the company (and I don't think they're anything but honest, dedicated scientists and enterprenours), the clinical results will be definitive. However, I always was very optimistic for broad reasons, such as the prominence of stem cells as a VERY promising technology, the numerous hints at efficacy from current clinical work, and my sense of the competence of the folks at Pluristem. In other words, if stem cells "work", this company has an excellent chance of being one of the leaders in the field.
As you said, the company's position today is as good as its ever been, and I expect very good things in the near future. Covid has turbo-charged and expedited our movement toward the goal.
I'm also glad to see some very savvy new posters (in addition to the handful we've had). The quality of the board has improved, as much by the additions as the absence missing ones (may they stay that way! LOL!)
Seems like the "DEAD MONEY" had a miraculous revival, I can hardly "belieb" it, BWAHAHAHAHA (with apologies to the new posters).
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM